ProCE Banner Activity

Advances in BTK Inhibitor Therapy for B-Cell Lymphomas: Expert Discussion and Resources to Elevate Patient Care

Slideset

Slides from a live webinar covering the latest advances in BTK inhibitor therapy for patients with B-cell lymphoma (CLL/SLL, MCL, and FL) for newly diagnosed or relapsed/recurrent disease, including those with BTK inhibitor resistance mutations.

Released: November 06, 2024

Expiration: November 05, 2025

Share

Faculty

Emily Patterson

Emily Patterson, AGACNP-BC

Massachusetts General Hospital
Lymphoma Clinic
Boston, Massachusetts

Provided by

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from BeiGene.

BeiGene

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner